Please Wait.....
Report
Dupuytrens Disease Therapeutics Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032
Market Report I 2024-08-06 I 119 Pages I Global Market Insights
Dupuytren's Disease Therapeutics Market is predicted to record a 12.2% CAGR over 2024-2032, driven by the increasing prevalence of Dupuytren's disease, particularly among the aging population. According to the WHO, the global population over 60 years will nearly double from 12% in 2015 to 22% by 2050. By 2030, 1 in 6 people will be 60 or older, increasing demand for age-related healthcare. As the global population ages, more individuals experience this condition, characterized by fingers bending inward due to thickened connective tissue in the hands. Advances in medical research and biotechnology have led to innovative solutions like collagenase injections and minimally invasive surgeries, which are gaining popularity for their effectiveness and quicker recovery times.
Increased awareness and diagnosis of Dupuytren's disease result in more timely treatments. Healthcare professionals and patients are recognizing the disease's symptoms earlier, prompting faster therapeutic responses. The expanding healthcare infrastructure in emerging nations, in consort with supportive government policies and reimbursement frameworks for innovative therapies, makes treatments more accessible and affordable for patients, facilitating market growth.
The overall Dupuytren's disease therapeutics industry is segmented based on type, therapeutics, distribution channel, and region.
The steroid segment is anticipated to gain significant traction through 2032, driven by the preference for non-surgical, less invasive treatment options among patients and healthcare providers. Steroids are relatively cost-effective and can be administered in outpatient settings, making them an accessible option for many patients. However, the segment faces competition from newer therapies, such as collagenase injections and surgical interventions, which offer more definitive solutions for advanced cases of Dupuytren's disease.
The online pharmacy segment will hold a notable market share by 2032, on account of the shift towards digital healthcare solutions. This channel offers patients the convenience of accessing medications from the comfort of their homes, which is particularly beneficial for those with limited mobility due to the disease. Online pharmacies often provide a wider range of therapeutic options and competitive pricing. Additionally, the ease of comparing products and accessing patient reviews enhances patient confidence in purchasing treatments online.
North America Dupuytren's Disease Therapeutics Market size will expand at a fast pace through 2032, driven by a high prevalence of the disease, advanced healthcare infrastructure, and strong investment in R and D. The region benefits from the presence of key pharmaceutical companies and cutting-edge medical facilities that support the development and adoption of innovative therapies, including collagenase injections and minimally invasive surgical procedures. Supportive regulatory frameworks and reimbursement policies in countries like the United States and Canada also enhance patient access to advanced therapeutics, solidifying North America's position as a lucrative avenue for market players.
Report Content
Chapter 1 Methodology and Scope
1.1 Market scope and definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates and calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 360 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence for dupuytren's disease
3.2.1.2 Advancements in drug delivery technologies
3.2.1.3 Rising geriatric population
3.2.2 Industry pitfalls and challenges
3.2.2.1 High research and development cost
3.2.2.2 Potential side effects and complications
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.5.1 Core technologies
3.5.2 Adjacent technologies
3.6 Pricing analysis, 2023
3.6.1 By region
3.6.2 By key player
3.7 Future market trends
3.8 Pipeline analysis
3.9 Porter's analysis
3.10 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Type, 2021 - 2032 ($ Mn)
5.1 Key trends
5.2 Type I
5.3 Type II
5.4 Type III
Chapter 6 Market Estimates and Forecast, By Therapeutics, 2021 - 2032 ($ Mn)
6.1 Key trends
6.2 Collagenase injection
6.3 Steroids
6.4 Immune-modulators
6.5 Other therapeutics
Chapter 7 Market Estimates and Forecast, By Distribution Channel, 2021 - 2032 ($ Mn)
7.1 Key trends
7.2 Retail pharmacy
7.3 Hospital pharmacy
7.4 Online pharmacy
Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)
8.1 Key trends
8.2 Europe
8.2.1 Germany
8.2.2 UK
8.2.3 France
8.2.4 Spain
8.2.5 Italy
8.2.6 Netherlands
8.2.7 Rest of Europe
8.3 North America
8.3.1 U.S.
8.3.2 Canada
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Rest of Latin America
8.6 Middle East and Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Rest of Middle East and Africa
Chapter 9 Company Profiles
9.1 AstraZeneca PLC
9.2 Actiza Pharmaceutical Private Limited
9.3 Bayer AG.
9.4 Bristol-Meyers Squibb Company
9.5 Endo International plc
9.6 Fresenius SE and Co. KGaA
9.7 Fortress Biotech, Inc.
9.8 GSK plc
9.9 Hikma Pharmaceuticals PLC
9.10 Johnson and Johnson
9.11 Merck and Co., Inc.
9.12 Nantong Jinghua Pharmaceutical Co., Ltd
9.13 Novartis AG
9.14 LEO Pharma A/S
9.15 Pfizer Inc.
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security